Quintiles has launched an Emerging Biopharma Solution, a new service offering designed to meet clinical development needs for emerging biopharma companies.
 
The new offering covers all therapeutic areas and adds to the oncology services of Novella Clinical, Quintiles’ oncology service provider for emerging biopharma customers. The newly developed operating model leverages Quintiles’ integrated technology platforms to provide real-time data access as well as a project performance transparency.
 
“Emerging biopharmaceutical companies have been important Quintiles customers throughout our 30+ year history, and we understand the unique challenges they face,” said Paula Brown Stafford, president of Clinical Development at Quintiles. “This new offering focuses squarely on those challenges – combining an operational model designed to meet these customers’ needs with access to Quintiles’ global infrastructure, integrated technology and therapeutic expertise. It is a combination we believe will help provide superior delivery and improve the probability of success for this customer segment.”